- Home
- ROIV vs BILI Comparison
ROIV vs BILI Comparison
Compare ROIV & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BILI
- Stock Information
- Founded
- ROIV 2014
- BILI 2009
- Country
- ROIV United Kingdom
- BILI China
- Employees
- ROIV N/A
- BILI N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BILI EDP Services
- Sector
- ROIV Health Care
- BILI Technology
- Exchange
- ROIV Nasdaq
- BILI Nasdaq
- Market Cap
- ROIV 8.8B
- BILI 8.3B
- IPO Year
- ROIV N/A
- BILI 2018
- Fundamental
- Price
- ROIV $11.57
- BILI $19.59
- Analyst Decision
- ROIV Strong Buy
- BILI Strong Buy
- Analyst Count
- ROIV 8
- BILI 10
- Target Price
- ROIV $17.93
- BILI $19.08
- AVG Volume (30 Days)
- ROIV 5.3M
- BILI 6.1M
- Earning Date
- ROIV 02-11-2025
- BILI 11-14-2024
- Dividend Yield
- ROIV N/A
- BILI N/A
- EPS Growth
- ROIV N/A
- BILI N/A
- EPS
- ROIV 5.89
- BILI N/A
- Revenue
- ROIV $129,128,999.00
- BILI $3,627,694,057.00
- Revenue This Year
- ROIV $15.98
- BILI $21.06
- Revenue Next Year
- ROIV N/A
- BILI $13.41
- P/E Ratio
- ROIV $2.06
- BILI N/A
- Revenue Growth
- ROIV 145.68
- BILI 14.00
- 52 Week Low
- ROIV $9.69
- BILI $8.80
- 52 Week High
- ROIV $13.06
- BILI $31.77
- Technical
- Relative Strength Index (RSI)
- ROIV 41.56
- BILI 48.27
- Support Level
- ROIV $11.72
- BILI $19.32
- Resistance Level
- ROIV $12.22
- BILI $20.10
- Average True Range (ATR)
- ROIV 0.30
- BILI 0.73
- MACD
- ROIV -0.09
- BILI 0.02
- Stochastic Oscillator
- ROIV 15.24
- BILI 18.04
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform that is best known for its video-sharing site that resembles YouTube. The site was founded in 2009 and started as a long-form video platform for anime, comics, and gaming, or ACG, content that appealed to Gen Z users. Since then, it has expanded its content on the platform to include a broader range of interests that have attracted Chinese users outside of the Gen Z cohort. The firm generates revenue through five main areas: advertising, games, live streaming, value-added services, and e-commerce.